Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myomo Inc (MYO)

Myomo Inc (MYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,256
  • Shares Outstanding, K 38,436
  • Annual Sales, $ 32,550 K
  • Annual Income, $ -6,180 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.17
  • Price/Sales 0.81
  • Price/Cash Flow N/A
  • Price/Book 2.07
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.29
  • Most Recent Earnings $-0.09 on 11/10/25
  • Next Earnings Date 03/09/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 374.98% (-105.81%)
  • Historical Volatility 63.60%
  • IV Percentile 78%
  • IV Rank 25.56%
  • IV High 1,273.78% on 09/18/25
  • IV Low 66.41% on 06/27/25
  • Expected Move (DTE 7) 0.2295 (27.98%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 72
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 7,534
  • Open Int (30-Day) 7,784
  • Expected Range 0.5908 to 1.0498

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.09
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -800.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7601 +7.92%
on 02/06/26
1.0200 -19.58%
on 01/22/26
-0.1242 (-13.15%)
since 01/13/26
3-Month
0.7110 +15.37%
on 11/19/25
1.1300 -27.41%
on 12/09/25
+0.0119 (+1.47%)
since 11/13/25
52-Week
0.7110 +15.37%
on 11/19/25
6.3000 -86.98%
on 02/14/25
-5.4897 (-87.00%)
since 02/13/25

Most Recent Stories

More News
Myomo Reports Third Quarter 2025 Financial and Operating Results

Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42...

MYO : 0.8203 (+0.87%)
Myomo to Report Third Quarter 2025 Financial Results on November 10

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8203 (+0.87%)
Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8203 (+0.87%)
Myomo Reports Second Quarter 2025 Financial and Operating Results

Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance ...

MYO : 0.8203 (+0.87%)
Myomo to Report Second Quarter 2025 Financial Results on August 11

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 0.8203 (+0.87%)
3 Underrated Robotics Stocks Poised for Major Growth

Robotics firms that may deserve a closer look by investors include AeroVironment, Cognex, and Myomo, all of which offer compelling products and tech.

NVDA : 182.81 (-2.21%)
CGNX : 58.79 (+0.20%)
MYO : 0.8203 (+0.87%)
AVAV : 243.87 (+3.72%)
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth

These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025.

MYO : 0.8203 (+0.87%)
FARO : 43.99 (+0.48%)
BRCHF : 0.1010 (-0.30%)
AI and Biotech Developers Lead the Charge in the Next Healthcare Transformation

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...

MYO : 0.8203 (+0.87%)
AVAI : 0.4318 (+7.39%)
PRCT : 27.79 (-1.07%)
ABSI : 2.55 (+5.37%)
ISRG : 485.84 (+1.51%)
Myomo to Report First Quarter Financial Results on May 10, 2023

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 0.8203 (+0.87%)
Myomo Receives Technology License Fee Payment from China Joint Venture Company

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 0.8203 (+0.87%)

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

3rd Resistance Point 0.8691
2nd Resistance Point 0.8496
1st Resistance Point 0.8349
Last Price 0.8203
1st Support Level 0.8007
2nd Support Level 0.7812
3rd Support Level 0.7665

See More

52-Week High 6.3000
Fibonacci 61.8% 4.1650
Fibonacci 50% 3.5055
Fibonacci 38.2% 2.8460
Last Price 0.8203
52-Week Low 0.7110

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar